ArticlePediatrics2022
Human Papillomavirus Vaccination Trends Among Adolescents: 2015 to 2020.
Article in Pediatrics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 18 citations in OpenAlex.
- Evaluation of a Minigrant Program for Multilevel Interventions to Promote Human Papillomavirus Vaccination in Rural Communities in Georgia.Preventing chronic disease · 2026Article
- HIV-Specific vs Universal Immunization Coverage in US Children with HIV: A Multi-Site Study.Journal of the Pediatric Infectious Diseases Society · 2026Article
- Declines in cervical cancer incidence among young women in the United States.Journal of the National Cancer Institute · 2026Article
- Changing pace of human papillomavirus vaccination among U.S. adolescents and young adults: the National Health and Nutrition Examination Survey, 2007-August 2023.Cancer causes & control : CCC · 2025Article
- "The big topic is COVID": A qualitative study about changes in HPV vaccine conversations between parents and primary care team members throughout the COVID-19 pandemic.Human vaccines & immunotherapeutics · 2025Article
- Sociodemographic Factors, Intent-Uptake Disparities, and Nirsevimab Availability in Infant RSV Immunoprophylaxis.Pediatric reports · 2025Article
- Electronic Health Record Clinical Decision Support to Close the Human Papillomavirus Vaccination Gender Disparity in Children Aged 9 and 10 Years.Clinical pediatrics · 2025Article
- Vaccine hesitancy or hesitancies? A latent class analysis of pediatric patients' parents.Clinical and translational science · 2025Article
- Association Between a Mother's Cervical Cancer Screening and Child's Human Papillomavirus (HPV) Vaccination Status.Maternal and child health journal · 2024Article
- Population-level impact of switching to 1-dose human papillomavirus vaccination in high-income countries: examining uncertainties using mathematical modeling.Journal of the National Cancer Institute. Monographs · 2024Article
- Associations of geographic-based socioeconomic factors and HPV vaccination among male and female children in five US states.BMC public health · 2024Article
- Trends in Adolescent Human Papillomavirus Vaccination and Parental Hesitancy in the United States.The Journal of infectious diseases · 2023Article
- Barriers to human papillomavirus vaccine uptake: role of state religiosity and healthcare professionals' participation in a state vaccine program.JNCI cancer spectrum · 2023Article
- Parental perceptions of the HPV vaccine for prevention of anogenital and oropharyngeal cancers.Vaccine: X · 2023Article
- Incidence of human papillomavirus-related cancers among males and females aged 15-34 years in the United States.JNCI cancer spectrum · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 1 institution in 1 country.
Funding
Abstract
objectiveTo assess trends in recent human papillomavirus (HPV) vaccination initiation and factors associated with vaccination among adolescents.
methodsThe 2015 to 2020 National Immunization Survey-Teen data were used to assess vaccination trends. Multivariable logistic regression analysis were conducted to assess factors associated with vaccination.
resultsOverall, HPV vaccination coverage (≥1 dose) among adolescents significantly increased from 56.1% in 2015 to 75.4% in 2020. There were larger increases in coverage among males (4.7 percentage points annually) than females (2.7 percentage points annually) and coverage differences between males and females decreased in 2015 through 2020. Coverage in 2020 was 75.4% for adolescents aged 13 to 17 years; 73.7% for males and 76.8% for females (P < .05); 80.7% for those with a provider recommendation and 51.7% for those without (P < .05); and 80.3% for those with a well child visit at age 11 to 12 years, and 64.8% for those without (P < .05). Multivariable logistic regression results showed that main characteristics independently associated with a higher likelihood of vaccination included: a provider recommendation, age 16 to 17 years, non-Hispanic Black, Hispanic, or American Indian or Alaskan Native, Medicaid insurance, ≥2 provider contacts in the past 12 months, a well-child visit at age 11 to 12 years and having 1 or 2 vaccine providers (P < .05).
conclusionsOverall, HPV vaccination coverage among adolescents increased during 2015 to 2020. Coverage increased faster among males than females and differences by sex narrowed during this time. Receiving a provider recommendation vaccination was important to increase vaccination coverage.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.